Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors

BJU International

Volumn 103, Issue 10, 2009, Pages 1392-1395

  Taylor, Joby ^a   Baldo, Omer B ^b   Storey, Anne ^b   Cartledge, Jon ^b   Eardley, Ian ^b  

^a YORK HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Erectile dysfunction; PDE5; Side effects; Sildenafil; Tadalafil; Vardenafil

Indexed keywords

SILDENAFIL; TADALAFIL; VARDENAFIL; CARBOLINE DERIVATIVE; IMIDAZOLE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; BACKACHE; BOTHERSOMENESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; VISUAL ANALOG SCALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUESTIONNAIRE; TIME;

CARBOLINES; ERECTILE DYSFUNCTION; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; PURINES; QUESTIONNAIRES; SULFONES; TIME FACTORS; TRIAZINES;

EID: 66149101330     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08328.x     Document Type: Article

References (16)

1. Nichols DJ, Muirhead GJ, Harness JA. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol 2002 53 (Suppl. 1 5S 12S
2. Stark S, Sachse R, Liedl T et al. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose. Eur Urol 2001 40 : 181 8
3. Forgue ST, Patterson BE, Bedding AW et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol 2006 61 : 280 8
4. Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract 2002 56 : 453 9
5. Lewis RW, Sadovsky R, Eardley I et al. The efficacy of tadalafil in clinical populations. J Sex Med 2005 2 : 517 31
6. Hellstrom WJ, Gittelman M, Karlin G et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002 23 : 763 71
7. Padma-Nathan H, Steers WD, Wicker PA. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. The Sildenafil Study Group. Int J Clin Pract 1998 52 : 375 9
8. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wickers PA. Oral sildenafil in the treatment of erectile dysfunction. The Sildenafil Study Group. N Engl J Med 1998 338 : 1397 404
9. Carson CC, Rajfer J, Eardley I et al. The efficacy and safety of tadalafil: an update. BJU Int 2004 93 : 1276 81
10. Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002 162 : 1349 60
11. von Keitz A, Rajfer J, Segal S et al. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. Eur Urol 2004 45 : 499 507
12. Tolrà JR, Campaña JM, Ciutat LF, Miranda EF. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors. J Sex Med 2006 3 : 901 9
13. Govier F, Potempa AJ, Kaufman J, Denne J, Kovalenko P, Ahuja S. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction. Clin Ther 2003 25 : 2709 23
14. Hatzichristou D, Haro JM, Martin-Morales A et al. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. Int J Clin Pract 2007 61 : 1850 62
15. Corbin JD, Francis SH. Molecular biology and pharmacology of PDE-5-Inhibitor therapy for erectile dysfunction. J Androl 2003 24 (Suppl. 38 41
16. Saenz de Tejada I, Angulo J, Gadau M et al. Comparative selectivity profiles of tadalafil, sildenafil and vardenafil using an in vitro phosphodiesterase activity assay. Int J Impot Res 2002 14 (Suppl. 3 S25